Patents by Inventor Gon Yi

Gon Yi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10330682
    Abstract: A composition, for diagnosing the possibility of onset of pancreatic cancer including an agent measuring the expression level of marker protein of diagnosing the possibility of onset of pancreatic cancer, or mRNA expression level of a gene encoding the protein, a kit including the composition, and a method of diagnosing pancreatic cancer using the maker are provided. The diagnostic markers of pancreatic cancer in accordance with the present disclosure are useful for predicting or diagnosing the onset, the possibility of onset, and the severity of pancreatic cancer in an early stage, and are also applied to a study on the tumorigenesis of pancreatic cancer. In addition, the diagnosis method of the present invention allows for the convenient detection of pancreatic cancer in a non-invasive manner in a sample such as blood.
    Type: Grant
    Filed: October 31, 2014
    Date of Patent: June 25, 2019
    Assignees: SK TELECOM CO., LTD., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Sangjo Han, Yonghwan Choi, Sung Gon Yi, Taegyun Yun, Junghyun Namkung, Youngsoo Kim, Taesung Park, Jin-Young Jang
  • Patent number: 10215756
    Abstract: The present invention relates to: a composition for diagnosing pancreatic cancer, containing a preparation for measuring the expression level of a protein or a gene thereof, and capable of being used for determining whether there is a risk of pancreatic cancer; a kit; and a method for diagnosing pancreatic cancer by using the same. The present invention can significantly predict or identify the risk of pancreatic cancer or a precancerous lesion of pancreatic cancer, the early diagnosis thereof and the extent of diseases thereof by providing a diagnostic marker of pancreatic cancer, and can be utilized in the research of pancreatic cancer oncogenesis. In addition, the diagnostic method of the present invention can provide simple and early diagnosis of pancreatic cancer from the blood and the like in a non-invasive manner.
    Type: Grant
    Filed: May 24, 2018
    Date of Patent: February 26, 2019
    Assignees: SK TELECOM CO., LTD., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Yonghwan Choi, Junghyun Namkung, Sung Gon Yi, Sangjo Han, Jin-Young Jang, Taesung Park, Youngsoo Kim
  • Publication number: 20180267045
    Abstract: The present invention relates to: a composition for diagnosing pancreatic cancer, containing a preparation for measuring the expression level of a protein or a gene thereof, and capable of being used for determining whether there is a risk of pancreatic cancer; a kit; and a method for diagnosing pancreatic cancer by using the same. The present invention can significantly predict or identify the risk of pancreatic cancer or a precancerous lesion of pancreatic cancer, the early diagnosis thereof and the extent of diseases thereof by providing a diagnostic marker of pancreatic cancer, and can be utilized in the research of pancreatic cancer oncogenesis. In addition, the diagnostic method of the present invention can provide simple and early diagnosis of pancreatic cancer from the blood and the like in a non-invasive manner.
    Type: Application
    Filed: May 24, 2018
    Publication date: September 20, 2018
    Inventors: Yonghwan Choi, Junghyun Namkung, Sung Gon Yi, Sangjo Han, Jin-Young Jang, Taesung Park, Youngsoo Kim
  • Patent number: 9983208
    Abstract: The present invention relates to: a composition for diagnosing pancreatic cancer, containing a preparation for measuring the expression level of a protein or a gene thereof, and capable of being used for determining whether there is a risk of pancreatic cancer; a kit; and a method for diagnosing pancreatic cancer by using the same. The present invention can significantly predict or identify the risk of pancreatic cancer or a precancerous lesion of pancreatic cancer, the early diagnosis thereof and the extent of diseases thereof by providing a diagnostic marker of pancreatic cancer, and can be utilized in the research of pancreatic cancer oncogenesis. In addition, the diagnostic method of the present invention can provide simple and early diagnosis of pancreatic cancer from the blood and the like in a non-invasive manner.
    Type: Grant
    Filed: September 18, 2015
    Date of Patent: May 29, 2018
    Assignees: SK TELECOM CO., LTD., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Yonghwan Choi, Junghyun Namkung, Sung Gon Yi, Sangjo Han, Jin-Young Jang, Taesung Park, Yongsoo Kim
  • Patent number: 9768959
    Abstract: Static security credentials are replaced by pseudonyms and session-specific passwords to increase security associated with user login attempts, and specifically to defeat keylogging attacks. For each login event, the system generates unique, session-specific credentials by randomly replacing characters within a given username and password. The random character generation ensures that system login attempts use different combinations of characters, thereby producing a new username and password for every user session. The client side of the system requires only the capability to display an image file, with specialized software/hardware limited to the server side, thereby facilitating the use of the system by a wide range of client devices.
    Type: Grant
    Filed: March 10, 2015
    Date of Patent: September 19, 2017
    Assignee: Acxiom Corporation
    Inventors: Gon Yi, William C. Smith, Connie Marie Ardwin
  • Publication number: 20170212119
    Abstract: The present invention relates to: a composition for diagnosing pancreatic cancer, containing a preparation for measuring the expression level of a protein or a gene thereof, and capable of being used for determining whether there is a risk of pancreatic cancer; a kit; and a method for diagnosing pancreatic cancer by using the same. The present invention can significantly predict or identify the risk of pancreatic cancer or a precancerous lesion of pancreatic cancer, the early diagnosis thereof and the extent of diseases thereof by providing a diagnostic marker of pancreatic cancer, and can be utilized in the research of pancreatic cancer oncogenesis. In addition, the diagnostic method of the present invention can provide simple and early diagnosis of pancreatic cancer from the blood and the like in a non-invasive manner.
    Type: Application
    Filed: September 18, 2015
    Publication date: July 27, 2017
    Inventors: Yonghwan CHOI, Junghyun NAMKUNG, Sung Gon YI, Sangjo HAN, Jin-Young JANG, Taesung PARK, Yongsoo KIM
  • Patent number: 9594742
    Abstract: A method and apparatus for matching equivalent words across languages takes advantage of a set of rules that are built from a user-defined language specification (UDLS), which may be open source and customizable by a language expert. The UDLS is used to build a customer language library (CLL) that includes a list of consonants, a list of vowels, and rules defining phoneme equivalencies across two languages. The CLL is used to match equivalent words by both two-set and three-set matching to not only increase the number of true matches (i.e., overall accuracy), but also improve recognition of variations in a manner that is not language specific.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: March 14, 2017
    Assignee: Acxiom Corporation
    Inventors: Gon Yi, Aaron Miyahira, Pavan Marupally
  • Publication number: 20160252512
    Abstract: A composition, for diagnosing the possibility of onset of pancreatic cancer including an agent measuring the expression level of marker protein of diagnosing the possibility of onset of pancreatic cancer, or mRNA expression level of a gene encoding the protein, a kit including the composition, and a method of diagnosing pancreatic cancer using the maker are provided. The diagnostic markers of pancreatic cancer in accordance with the present disclosure are useful for predicting or diagnosing the onset, the possibility of onset, and the severity of pancreatic cancer in an early stage, and are also applied to a study on the tumorigenesis of pancreatic cancer. In addition, the diagnosis method of the present invention allows for the convenient detection of pancreatic cancer in a non-invasive manner in a sample such as blood.
    Type: Application
    Filed: October 31, 2014
    Publication date: September 1, 2016
    Inventors: Sangjo HAN, Yonghwan CHOI, Sung Gon YI, Taegyun YUN, Junghyun NAMKUNG, Youngsoo KIM, Taesung PARK, Jin-Young JANG
  • Publication number: 20160117510
    Abstract: Static security credentials are replaced by pseudonyms and session-specific passwords to increase security associated with user login attempts, and specifically to defeat keylogging attacks. For each login event, the system generates unique, session-specific credentials by randomly replacing characters within a given username and password. The random character generation ensures that system login attempts use different combinations of characters, thereby producing a new username and password for every user session. The client side of the system requires only the capability to display an image file, with specialized software/hardware limited to the server side, thereby facilitating the use of the system by a wide range of client devices.
    Type: Application
    Filed: March 10, 2015
    Publication date: April 28, 2016
    Inventors: Gon Yi, William C. Smith, Connie Marie Ardwin
  • Publication number: 20160078169
    Abstract: The present disclosure provides a method for providing information about a gene sequence-based personal marker. The method includes: obtaining base sequence-related information from a target sample; performing a quality control of a base sequence corresponding to the base sequence-related information obtained from the target sample; comparing the base sequence, for which the quality control is performed, with a reference sequence; extracting a personal identification genetic variation marker from a result of the sequence comparison; evaluating optimality of the extracted personal identification genetic variation marker; and outputting a sequence corresponding to a personal identification genetic variation marker having the evaluated optimality which is higher than a predetermined level.
    Type: Application
    Filed: August 3, 2015
    Publication date: March 17, 2016
    Inventors: Jung Hyun NAMKUNG, Tae Gyun YUN, Sung Gon YI, Byung Chul LEE
  • Publication number: 20150066474
    Abstract: A method and apparatus for matching equivalent words across languages takes advantage of a set of rules that are built from a user-defined language specification (UDLS), which may be open source and customizable by a language expert. The UDLS is used to build a customer language library (CLL) that includes a list of consonants, a list of vowels, and rules defining phoneme equivalencies across two languages. The CLL is used to match equivalent words by both two-set and three-set matching to not only increase the number of true matches (i.e., overall accuracy), but also improve recognition of variations in a manner that is not language specific.
    Type: Application
    Filed: July 17, 2014
    Publication date: March 5, 2015
    Inventors: Gon Yi, Aaron Miyahira, Pavan Marupally